Buprenorphine and Acute Surgical Pain
A 34-year-old man (BMI 31) with opioid use disorder in remission for six years takes buprenorphine–naloxone 8/2 mg twice daily; his last dose was ten hours ago. He fell while cycling and has a closed, displaced distal radius fracture. The hand surgeon wants to operate in eight hours, which is feasible because the patient is otherwise fasting and healthy. He is anxious, remembers being told years ago that 'buprenorphine blocks pain medicine completely,' and asks whether he should skip his doses so the operation will 'work.' He takes no other medication. Vital signs and laboratory results are unremarkable, and he is not in withdrawal. The anesthesiologist covering the case has never managed a patient on buprenorphine and asks you how to plan intraoperative and postoperative analgesia.
1. Should the patient hold, reduce, or continue his buprenorphine–naloxone around surgery? Explain the pharmacology behind your advice and what you tell him about 'blocks pain medicine.'
Read the worked answer
Continue the usual dose. Continuing is the recommendation of both addiction and perioperative pain guidance, and the reasons are mechanistic:
- Buprenorphine is a high-affinity partial mu agonist with slow dissociation. At steady state it occupies most receptors, which produces a ceiling on respiratory depression and, to a lesser degree, on analgesia. Full agonists must compete for the same site, so their effect is attenuated in a dose-dependent way - but the attenuation is surmountable with higher agonist concentrations, not absolute.
- Abrupt discontinuation risks withdrawal (tachycardia, hypertension, agitation, diarrhoea), destabilizes a six-year remission, and does not reliably restore full-agonist sensitivity within the surgical window anyway.
- Splitting the total daily dose (4 mg four times daily) smooths levels; some clinicians reduce to 8 mg/day when preoperative analgesia is critical, but there is no strong evidence that reduction improves outcomes and it adds withdrawal risk.
What to tell him: 'blocks pain medicine completely' is a myth from the era of high-dose monotherapy. The truthful version is that he will need more opioid than a similar patient without buprenorphine, that we will not rely on opioids alone, and that he should take his evening and morning doses as prescribed. Document this conversation; it also protects him from being labelled opioid-seeking when he reports severe pain.
2. Design the intraoperative and immediate postoperative analgesic plan, naming specific drugs and the contingencies if pain is poorly controlled.
Read the worked answer
Anchor the plan in regional anesthesia, then build multimodal layers.
- Block: an ultrasound-guided supraclavicular or axillary brachial plexus block with a perineural catheter. For a distal radius fracture this is the single highest-yield intervention: it removes the intraoperative opioid requirement almost entirely and lets you titrate local anesthetic post-operatively.
- Intraoperative: propofol/remifentanil or volatile anesthesia plus dexmedetomidine 0.3–0.5 mcg/kg/h as an adjunct; ketamine 0.3 mg/kg bolus then 0.1–0.2 mg/kg/h reduces wind-up and opioid tolerance.
- Postoperative: scheduled acetaminophen 1 g every 6 h, an NSAID if renal function and bone healing permit, and oral or IV opioid titrated in small increments with monitoring.
If pain is still severe despite the block:
- Verify catheter position and spread before escalating opioids.
- Increase the full agonist substantially - for example hydromorphone 0.5 mg increments rather than 0.2 mg - and reassess in 10–15 minutes. Under-dosing out of fear of the buprenorphine interaction is the commonest error.
- Avoid agonist–antagonist mixtures (butorphanol, nalbuphine), which can precipitate withdrawal.
- If respiratory depression occurs, naloxone still works; titrate 40–80 mcg increments so you reverse hypoventilation without triggering full withdrawal.
3. The surgeon proposes discharging him the same evening with 30 oxycodone tablets. How do you respond, and what safeguards do you build into the discharge plan?
Read the worked answer
Judgment: this is the highest-risk moment in the entire episode, not the anesthetic.
A patient with opioid use disorder in sustained remission, receiving a large discharge opioid supply after a painful operation, faces a real risk of return to misuse and diversion. At the same time, undertreating post-discharge pain drives illicit use and relapse. Neither reflex - refuse opioids, or hand over thirty tablets - is correct.
Plan
- Keep the perineural catheter or place a single-injection long-acting block so the first 24–48 h, historically the worst, are covered without oral opioids.
- Coordinate with addiction medicine before discharge; continue buprenorphine–naloxone at the same dose without interruption.
- If an opioid is needed: a small quantity (for example 5–7.5 mg oxycodone equivalents every 6 h as needed, no more than a five-day supply), no refills, single prescriber, check the prescription drug monitoring program, and dispense naloxone with instruction for a household member.
- Explicit follow-up: a telephone check within 48–72 h and a clinic visit within a week; warn the patient that a request for early refill will trigger a conversation, not a dismissal.
- Document the shared decision so the next clinician does not read a small prescription as under-treatment of pain.